SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a …
BOSTON--(BUSINESS WIRE)--Dec 18, 2024--
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Dec 18, 2024--
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manu…
BURLINGTON, Mass.--(BUSINESS WIRE)--Dec 17, 2024--
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for …
TN-201 Well Tolerated at 3E13 vg/kg Dose
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Dec 17, 2024--
FRISCO, Texas & FARRAGUT, Tenn.--(BUSINESS WIRE)--Dec 17, 2024--
NEW YORK--(BUSINESS WIRE)--Dec 17, 2024--
